Favorable results of allogeneic bone marrow transplantation (BMT) for adults with Philadelphia (Ph)-chromosome-negative acute lymphoblastic leukemia (ALL) in first complete remission (CR): Results from the International ALL trial (MRC UKALL XII/ECOG E2993).

Rowe, J; Richards, S; Burnett, A; Wiernik, P; Harrison, G; Lazarus, H; Franklin, I; Prentice, G; Durrant, J; Tallman, MS; Goldstone, A

Journal article

Favorable results of allogeneic bone marrow transplantation (BMT) for adults with Philadelphia (Ph)-chromosome-negative acute lymphoblastic leukemia (ALL) in first complete remission (CR): Results from the International ALL trial (MRC UKALL XII/ECOG E2993).

Publication status:: Published

Actions

Email

Email this record

Send the bibliographic details of this record to your email address.

Your Email
Please enter the email address that the record information will be sent to.

-
Your message (optional)
Please add any additional information to be included within the email.
Cite

Cite this record

APA Style

Rowe, J., Richards, S., Burnett, A., Wiernik, P., Harrison, G., Lazarus, H., Franklin, I., Prentice, G., Durrant, J., Tallman, M. S., & Goldstone, A. (2016). Favorable results of allogeneic bone marrow transplantation (BMT) for adults with Philadelphia (Ph)-chromosome-negative acute lymphoblastic leukemia (ALL) in first complete remission (CR): Results from the International ALL trial (MRC UKALL XII/ECOG E2993). BLOOD, 98(11), 481A–481A.

MLA Style

Rowe, J., et al. “Favorable Results of Allogeneic Bone Marrow Transplantation (BMT) for Adults with Philadelphia (Ph)-Chromosome-Negative Acute Lymphoblastic Leukemia (ALL) in First Complete Remission (CR): Results from the International ALL Trial (MRC UKALL XII/ECOG E2993).” BLOOD, vol. 98, no. 11, 2016, pp. 481A–481A.

Chicago Style

Rowe, J, S Richards, A Burnett, P Wiernik, G Harrison, H Lazarus, I Franklin, et al. 2016. “Favorable Results of Allogeneic Bone Marrow Transplantation (BMT) for Adults with Philadelphia (Ph)-Chromosome-Negative Acute Lymphoblastic Leukemia (ALL) in First Complete Remission (CR): Results from the International ALL Trial (MRC UKALL XII/ECOG E2993).” BLOOD 98 (11): 481A–481A.
Tweet
Print